Interpretation of and alternatives to p-values in biomedical sciences

2022

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.17816/humeco97249
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Existing difficulties in interpretation of the results of statistical analysis have been repeatedly mentioned as one of the factors behind poor reproducibility of research findings in biomedical sciences followed by a series of publications presenting alternatives to improve the situation including a abandonment of p-values and significance testing. In this paper we briefly present the scope of the problem as well as Fischer and NeymanPearson approaches to hypothesis testing. Moreover, we present confidence intervals and effect size calculation as alternatives to dichotomization of the results as significant or not significant using a certain cut-off level. In addition, we summarize the pros and cons of suggestion to change the cut-off value from traditional 0.05 to 0.005. We also present a list of the most common misunderstandings of p-values discussed in international statistical literature. We conclude the paper with brief recommendations on careful interpretation of the results of statistical analysis to prevent misinterpretation and misuse of p-values in biomedical studies.